GF Fund Management
KURA icon

GF Fund Management’s Kura Oncology KURA Stock Holding History

GF Fund Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.5K Buy
2,007
+164
+9% +$1.83K ﹤0.01% 484
2026
Q2 		$20.2K Sell
1,843
-101
-5% -$953 ﹤0.01% 480
2026
Q1 		$15.8K Buy
1,944
+234
+14% +$2.01K ﹤0.01% 521
2025
Q4 		$17.8K Sell
1,710
-157
-8% -$1.65K ﹤0.01% 520
2025
Q3 		$16.5K Sell
1,867
-124
-6% -$884 ﹤0.01% 509
2025
Q2 		$11.5K Hold
1,991
– – ﹤0.01% 555
2025
Q1 		$13.1K Buy
1,991
+358
+22% +$2.79K ﹤0.01% 531
2024
Q4 		$14.2K Buy
+1,633
New +$23.5K ﹤0.01% 505

Other funds holding KURA

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Xcel Wealth Management
Xcel Wealth Management Holly Hill, Florida $404M AUM 16.8% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
Achmea Investment Management
Achmea Investment Management Zeist, Netherlands $12.6B AUM 25.68% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

GF Fund Management's KURA Position: Q3 2026 in Review

GF Fund Management increased its Kura Oncology (KURA) stake by 8.9% in Q3 2026, buying an estimated $1.83K and bringing the position to 2,007 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

GF Fund Management first reported a position in KURA in Q4 2024 and has held it in 8 quarters since. 49 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • GF Fund Management held 2,007 shares of Kura Oncology worth $21.5K as of Q3 2026.
  • GF Fund Management bought 164 Kura Oncology shares in Q3 2026, an estimated $1.83K.
  • Kura Oncology made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #484 holding.
  • GF Fund Management first reported a position in Kura Oncology in Q4 2024 and has held it in 8 quarters since.
  • 49 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.